DUBLIN--(BUSINESS WIRE)--The "Global Intrauterine Contraceptive Devices (IUD) Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
The intrauterine contraceptive devices (IUD) market is poised to grow by $ 597.40 mn during 2020-2024 progressing at a CAGR of 3% during the forecast period.
The market is driven by the initiatives taken by governments and non-profit organizations and the effectiveness of IUDs.
The report on the intrauterine contraceptive devices (IUD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The intrauterine contraceptive devices (IUD) market analysis includes end-user segment and geographical landscapes.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading intrauterine contraceptive devices (IUD) market vendors that include AbbVie Inc., Bayer AG, DKT International, EUROGINE SL, Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Mylan NV, Pregna International Ltd., Prosan International BV, and The Cooper Companies Inc.
Also, the intrauterine contraceptive devices (IUD) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Key Topics Covered:
Executive Summary
- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by End-user
- Market segments
- Comparison by End-user
- Hospitals - Market size and forecast 2019-2024
- Gynecology clinics - Market size and forecast 2019-2024
- Others - Market size and forecast 2019-2024
- Market opportunity by End-user
Market Segmentation by Type
- Market segments
- Comparison by Type
- Hormonal intrauterine device - Market size and forecast 2019-2024
- Copper intrauterine device - Market size and forecast 2019-2024
- Market opportunity by Type
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- Europe - Market size and forecast 2019-2024
- North America - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- AbbVie Inc.
- Bayer AG
- DKT International
- EUROGINE SL
- Laboratoire HRA Pharma SAS
- Melbea Innovations Ltd.
- Mylan NV
- Pregna International Ltd.
- Prosan International BV
- The Cooper Companies Inc.
Appendix
For more information about this report visit https://www.researchandmarkets.com/r/9wz9od.
